United States Antimony (UAMY) Earnings Analysis
United States Antimony (UAMY) next reports earnings on 2026-08-11, consensus EPS -0.02 USD. Last quarter (2026-05-14) it missed with EPS -0.08 USD vs -0.02 USD est (-300%). It has beaten estimates in 2/5 recent quarters (40%). Trailing P/E -48.42.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does UAMY next report earnings?
| Next earnings date | 2026-08-11 |
|---|---|
| Consensus EPS estimate | -0.02 USD |
| Revenue estimate | 0.02B |
UAMY earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | -0.08 USD | -0.02 USD | -300% | Miss |
| 2026-03-19 | -0.01 USD | -0.01 USD | 0% | Beat |
| 2025-11-12 | -0.04 USD | 0.02 USD | -300% | Miss |
| 2025-08-12 | 0.00143 USD | 0.01 USD | -85.7% | Miss |
| 2025-03-20 | -0.01 USD | -0.01 USD | 0% | Beat |
| 2024-08-09 | 0.00186 USD | n/a | n/a | n/a |
Beat rate: 2/5 (40%) over reported quarters with consensus data.
UAMY valuation and analyst view
| Trailing P/E | -48.42 |
|---|---|
| Trailing EPS | -0.11426 USD |
| Price / book | 6.27 |
| Dividend yield | 0.00% |
| Market cap | 0.88B |
| Analyst consensus | Buy (4 buy / 0 hold / 0 sell) |
| Avg price target | 11.75 USD |
Related research pages
Frequently asked questions
When is United States Antimony (UAMY)'s next earnings date?
United States Antimony is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.02 USD and revenue estimate of 0.02B.
Did UAMY beat earnings last quarter?
In its 2026-05-14 report, UAMY posted EPS of -0.08 USD versus a -0.02 USD estimate — a miss of 300%.
What is UAMY's earnings track record?
Over the last 5 reported quarters with consensus data, UAMY beat estimates 2 times (40%).
What is UAMY's current P/E ratio and EPS?
UAMY trades at a trailing P/E of -48.42 on trailing EPS of -0.11425946312710666 USD.
What do analysts rate UAMY?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 11.75 USD.